# Intracavernosal Exosomes vs. Rectal Ozone for Post-RARP Erectile Dysfunction

> **NCT07707505** · NA · NOT_YET_RECRUITING · sponsor: **Medipol University** · enrollment: 60 (estimated)

## Conditions studied

- Erectile Dysfunction Following Radical Prostatectomy

## Interventions

- **BIOLOGICAL:** Urine-Derived Exosomes (USC-Exos)
- **PROCEDURE:** Rectal Medical Ozone Insufflation
- **DRUG:** Daily Phosphodiesterase type 5 (PDE5) Inhibitor

## Key facts

- **NCT ID:** NCT07707505
- **Lead sponsor:** Medipol University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-08-01
- **Primary completion:** 2027-01-01
- **Final completion:** 2027-04-01
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-07-16

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07707505

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07707505, "Intracavernosal Exosomes vs. Rectal Ozone for Post-RARP Erectile Dysfunction". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07707505. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*